Latest News and Press Releases

OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities

BPM31510 provides encouraging evidence of the potential for transformative benefit for a disease with high unmet need, supporting further development.The Company plans to seek guidance in Q3 2025 from...

SplashBIO™: A biomarker platform for clinical trials that uses biomarker tests to accelerate enrollment, save money, and reduce screen failure rates.

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. ...

- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine...

New Taipei City, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Yseop, the global leader in Generative AI for life sciences, today announced the next phase in delivering its One-Click Dossier vision, a scalable...

Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030" report has been added to ...

Dallas, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal clinical trial, which aims to improve...

Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply & Logistics for Pharmaceutical Market by Service Type, End User, Phase, Transportation Mode, Temperature Range, Packaging...